Company / Operating Income per Share
Bio-Rad Laboratories Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.62
FY2025
5-year range
$1.62 / $16.58
FY2021-FY2025
Trend
-82.1%
vs FY2024
Sector context
#75 of 154
Health Care
What the data says
At $1.62, Bio-Rad Laboratories's operating income per share ranks #75 of 154 in the Health Care sector. Operating Income per Share has declined for 4 consecutive years, from $16.58 in FY2021 to $1.62 in FY2025.
Based on SEC 10-K filings.
1.62 in FY2025 with a 3-year CAGR of -53.4%.
Declined from $11.18 to $1.62 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -53.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#75 of 154 in Health CareTop 49% of 154This company $1.62 Sector average $4.25
▼
-62.0% below sector average
Key checks
Key Insights
- Bio-Rad Laboratories's operating income per share has declined for 4 consecutive years.
- In FY2025, operating income per share decreased 82.1% year-over-year.
- Ranks #75 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.62 | -82.1% |
| FY2024 | $9.03 | -19.2% |
| FY2023 | $11.18 | -30.1% |
| FY2022 | $16.00 | -3.5% |
| FY2021 | $16.58 | +584.9% |
| FY2020 | -$3.42 | -144.7% |
| FY2019 | $7.65 | +306.9% |
| FY2018 | $1.88 | -66.8% |
| FY2017 | $5.67 | +10.1% |
| FY2016 | $5.15 | -10.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026